Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Bowman, Natalie M ^a,c   Congdon, Seth ^a   Mvalo, Tisungane ^b   Patel, Jaymin C ^c   Escamilla, Veronica ^d   Emch, Michael ^d   Martinson, Francis ^a,b   Hoffman, Irving ^a,b   Meshnick, Steven R ^c   Juliano, Jonathan J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina Project   (Malawi)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; PROTOZOAL PROTEIN;

ADULT; ANIMAL; ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMISTRY; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; MALAWI; MALE; METABOLISM; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD;

ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MALAWI; MALE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84879672017     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01990     Document Type: Article

References (38)

1. World Health Organization. World Malaria Report 2012. WHO Publications: Geneva, (2012).
2. RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. New Engl J Med. 365, 1863-1875 (2011).
3. RTS,S Clinical Trials Partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. New Engl J Med. 367, 2284-2295 (2012).
4. Olutu, A., Fegan, G.& Wambua, J. et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. New Engl J Med. 368, 1111-1120 (2013).
5. Calvo-Calle, J. M. et al. Immunogenecity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. J Immunol. 150, 1403-1412 (1993). (Pubitemid 23127430)
6. Zeeshan, M. et al. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. PLoS One. 7, e43430. doi:10.1371/journal.pone.0043430 (2012).
7. Putaporntip, C., Jongwutiwes, S. & Hughes, A. L. Natural selection maintains a stable polymorphism at the circumsporozoite protein locus of Plasmodium falciparum in a low endemic area. Infect Genet Evol. 9, 567-573 (2009).
8. Casares, S., Brumeanu, T. D. & Richie, T. L. The RTS,S malaria vaccine. Vaccine. 28, 4880-4894 (2010).
9. Rich, S. M., Ferreira, M. U. & Ayala, F. J. The origin of antigenic diversity in Plasmodium falciparum. Parasitol Today. 16, 390-396 (2000). (Pubitemid 30624170)
10. Kyabayinze, K. D. et al. Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children. African Health Sci. 8, 200-205 (2008).
11. Lee, S. A. et al. Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda. J Infect Dis. 193, 1160-1163 (2006).
12. Alloueche, A. et al. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hygiene 68, 97-101 (2003). (Pubitemid 38234855)
13. Enosse, S. et al. RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials. 1, e5. doi:10.1371/journal.pctr.0010005 (2006).
14. Waitumbi, J. N. et al. Impact of RTS,S/AS02A and RTS,S/AS01B on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS One. 4, e7849 (2009).
15. Thera, M. A. et al.Afield trial to assess a blood-stage malaria vaccine. NEngl J Med 365, 1004-1013 (2011).
16. Alam, M. T. et al. Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob Agents Chemother 55, 155-164 (2011).
17. Griffing, S. M. et al. South American Plasmodium falciparum after the Malaria Eradication Era: clonal population expansion and survival of the fittest hybrids. PloS one 6, e23486 (2011).
18. Rebaudet, S. et al. Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis 16, 1686-1694 (2010).
19. Schultz, L. et al. Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in PapuaNew Guinea, a region of intense perennial transmission. Malaria J 9, 336-348 (2010).
20. Bailey, J. A. et al. Diversity of and selection on Plasmodium falciparum csp T cell epitopes determined by massively parallel pyrosequencing in Lilongwe, Malawi. J Infect Dis 206, 580-587 (2012).
21. Magurran, A. E. Measuring Biological Diversity. Blackwell Publishing: Malden, MA (2007).
22. World Health Organization. Recommended genotyping procedures (RPGs) to identify parasite populations. Available online at http://www.who.int/malaria/ publications/atoz/rgptext-sti/en/index.html (2007).
23. Jongwutiwes, S. et al. Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates.AmJ Trop MedHyg. 51, 659-668 (1994). (Pubitemid 24378563)
24. Clark, T. D. et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 198, 393-400 (2008).
25. Greenhouse, B. et al. Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. J Infect Dis. 199, 758-65 (2009).
26. Ali, M. et al. Vaccination of adult women against cholera protects infants and young children in rural Bangladesh. Ped Infect Dis J 27, 33-37 (2008).
27. Ali, M. et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh. Lancet 366, 44-49 (2005). (Pubitemid 40956529)
28. Emch, M., Ali, M., Yunus, M., Sack, D., Acosta, C. & Clemens, J. D. Efficacy calculation in randomized vaccine trials: global or local measures? Health and Place 13, 238-248 (2007). (Pubitemid 44750823)
29. Emch, M., Ali, M., Yunus, P., Park, J. K., Yunus, M., Sack, D. & Clemens, J. D. Int J Epidemiol 35, 1044-1050 (2006).
30. Malawi Census. Available online at http://www.maseda.mw/censusinfomw/.
31. National Statistical Office (NSO) and ICF Macro. Malawi Demographic and Health Survey 2010. Zomba, Malawi, and Calverton, Maryland, USA: NSO and ICF Macro (2011).
32. Malawi Ministry of Health. Malawi National Malaria Indicator Survey 2010. Lilongwe, Malawi: Malawi Ministry of Health (2010).
33. Colwell, R. K. EstimateS: Statistical estimation of species richness and shared species from samples. Version 8.2.User's Guide and application published at: http://purl.oclc.org/estimates (2009).
34. Gotelli, N. J. & Colwell, R. K. Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness. Ecology Letters. 4, 379-391 (2001). (Pubitemid 32752218)
35. Chao, A. Estimating population size for sparse data in capture-recapture experiments. Biometrics. 45, 427-438 (1989).
36. Peakall, R. & Smouse, P. E. GENALEX 6: genetic analysis in Excel. Population genetic software for teaching and research. Mol Ecol Notes. 6, 288-295 (2006). (Pubitemid 43373825)
37. Peakall, R. & Smouse, P. E. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics. doi:10.1093/bioinformatics/bts460 (2012).
38. Hedrick, P. W. Genetics of Populations. Third edition. Sudbury, Massachusetts: Jones and Bartlett (2005).